Literature DB >> 24959390

Congestive heart failure: a case of protein misfolding.

Chung-Eun Ha1, Nadhipuram V Bhagavan1, Miki Loscalzo1, Stephen K Chan1, Huy V Nguyen1, Carlos N Rios1, Stacey A A Honda1.   

Abstract

This article describes an interesting case of a patient presenting with congestive heart failure found to have restrictive cardiomyopathy with initial laboratory evaluation showing hypogammaglobuminemia without a monoclonal band on serum and urine electrophoresis. This case highlights the clinically significant cardiac manifestation caused by protein misfolding, a defect in protein homeostasis. In addition, the utility of a relatively newer laboratory test, serum free light chains as well as the importance of clinical and pathophysiologic correlation is also discussed. We present a relatively uncommon cause of heart disease, cardiac amyloidosis in a patient with a systemic plasma cell dyscrasia, and multiple myeloma.

Entities:  

Keywords:  cardiac amyloidosis; congestive heart failure; light chains; multiple myeloma; serum free

Mesh:

Year:  2014        PMID: 24959390      PMCID: PMC4064341     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  13 in total

Review 1.  Amyloidosis.

Authors:  M A Gertz; M Q Lacy; A Dispenzieri
Journal:  Hematol Oncol Clin North Am       Date:  1999-12       Impact factor: 3.722

2.  Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis.

Authors:  Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-Ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark
Journal:  Amyloid       Date:  2010-11-02       Impact factor: 7.141

Review 3.  Evaluating and managing hypogammaglobulinemia.

Authors:  Mark E Rose; David M Lang
Journal:  Cleve Clin J Med       Date:  2006-02       Impact factor: 2.321

Review 4.  Cardiac amyloidosis: a practical approach to diagnosis and management.

Authors:  Prashant Kapoor; Thenappan Thenappan; Ekta Singh; Shaji Kumar; Philip R Greipp
Journal:  Am J Med       Date:  2011-11       Impact factor: 4.965

Review 5.  Restrictive cardiomyopathy.

Authors:  S S Kushwaha; J T Fallon; V Fuster
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

6.  A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

Authors:  Ashutosh D Wechalekar; Stefan O Schonland; Efstathios Kastritis; Julian D Gillmore; Meletios A Dimopoulos; Thirusha Lane; Andrea Foli; Darren Foard; Paolo Milani; Lisa Rannigan; Ute Hegenbart; Philip N Hawkins; Giampaolo Merlini; Giovanni Palladini
Journal:  Blood       Date:  2013-03-11       Impact factor: 22.113

Review 7.  Autophagy in human health and disease.

Authors:  Augustine M K Choi; Stefan W Ryter; Beth Levine
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

8.  Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

Authors:  M Drayson; L X Tang; R Drew; G P Mead; H Carr-Smith; A R Bradwell
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

9.  Screening panels for detection of monoclonal gammopathies.

Authors:  Jerry A Katzmann; Robert A Kyle; Joanne Benson; Dirk R Larson; Melissa R Snyder; John A Lust; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Clin Chem       Date:  2009-06-11       Impact factor: 8.327

10.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more
  1 in total

1.  Serum Proteomic Changes in Dogs with Different Stages of Chronic Heart Failure.

Authors:  Ahmet Saril; Meric Kocaturk; Kazumi Shimada; Akiko Uemura; Emel Akgün; Pinar Levent; Ahmet Tarik Baykal; Alberto Muñoz Prieto; Carlos Fernando Agudelo; Ryou Tanaka; Jose Joaquin Ceron; Jorgen Koch; Zeki Yilmaz
Journal:  Animals (Basel)       Date:  2022-02-16       Impact factor: 2.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.